About this trial
Preserving primary teeth until their normal exfoliation time is crucial for maintaining the child's normal function, esthetics, arch integrity, and correct eruption of permanent successors. Given the growing interest in conservative procedures and the clinical need for simpler, more predictable pulp therapy outcomes in children, evaluating pulpotomy with Pulpotec as a potential alternative to pulpectomy is essential.
The aim of this study is to evaluate the clinical and radiographic success of pulpotomy using Pulpotec versus pulpectomy using Metapex, a calcium hydroxide with iodoform paste, to treat primary molars in children diagnosed with irreversible pulpitis or necrotic pulp in the Postgraduate Pediatric Dental Clinic at Ajman University, UAE. A total of 25 contralateral paired molar samples from children aged 4 to 8 will be included in this split-mouth randomized controlled study. Each child will serve as their own control, with one tooth randomized to the intervention group (Pulpotomy using Pulpotec) and the other to the control group (Pulpectomy using Metapex) to assess patients' clinical and radiographic outcomes over a 12-month follow-up period. Patients will have their dental anxiety psychometrically assessed using the RMS pictorial scale. In addition, a pulse oximeter will be used as a biological marker in the study to measure oxygen saturation and pulse rate.
Eligibility criteria
Qualifiers
Patients in healthy medical conditions
Bilateral/contralateral primary molars diagnosed with irreversible pulpitis or necrotic pulp
Periapical or bifurcation radiolucency
Chronic apical intraoral abscess
Disqualifiers
Patients who are medically compromised (with systemic conditions)
Acute extraoral abscess
Grade II or III tooth mobility
External root resorption in more than 1/3 of roots
Trial design
Treatments tested in this trial
- Pulpotomy
- Pulpectomy